for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China National Medicines Corporation Ltd

600511.SS

Latest Trade

25.26CNY

Change

0.08(+0.32%)

Volume

3,276,498

Today's Range

25.16

 - 

25.55

52 Week Range

20.71

 - 

30.94

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
25.18
Open
25.18
Volume
3,276,498
3M AVG Volume
117.06
Today's High
25.55
Today's Low
25.16
52 Week High
30.94
52 Week Low
20.71
Shares Out (MIL)
764.40
Market Cap (MIL)
19,058.75
Forward P/E
12.34
Dividend (Yield %)
1.58

Latest Developments

More

China National Medicines' 9-Mth Net Profit Up 12.7% Y/Y

China National Medicines' H1 Net Profit Up 18.7% Y/Y

China National Medicines Says 2018 Net Profit Up 23.0 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About China National Medicines Corporation Ltd

China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.

Industry

Medical Equipment & Supplies

Contact Info

No. 12A

Yongwai Sanyuan West Lane

Dongcheng District

+86.10.67271828

Executive Leadership

Xiuchang Jiang

Chairman of the Board

Lixin Shen

Chief Financial Officer

Zhiyuan Lu

Deputy General Manager, Secretary of the Board, Director

Renli Jin

Deputy General Manager

Wei Shao

Deputy General Manager

Key Stats

1.56 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

13.4K

2017

36.3K

2018

38.7K

2019(E)

42.6K
EPS (CNY)

2016

1.144

2017

1.550

2018

1.831

2019(E)

2.044
Price To Earnings (TTM)
12.66
Price To Sales (TTM)
0.45
Price To Book (MRQ)
1.93
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
18.08
LT Debt To Equity (MRQ)
2.16
Return on Investment (TTM)
18.11
Return on Equity (TTM)
7.82

Latest News

Latest News

BRIEF-China National Medicines Says Board Elects Jiang Xiuchang As Chairman

* SAYS BOARD ELECTS JIANG XIUCHANG AS CHAIRMAN Source text in Chinese: http://bit.ly/2BGnTIq Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-China National Medicines Expects 2017 Net Profit To Rise 100-120 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 100-120 PERCENT Y/Y VERSUS 547.6 MILLION YUAN ($86.56 million)YEAR AGO Source text in Chinese: http://bit.ly/2DHEcBL Further company coverage: ($1 = 6.3265 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-China National Medicines elects chairman

* SAYS BOARD ELECTS JIANG XIUCHANG AS CHAIRMAN, REPLACING LIU YONG Source text in Chinese: http://bit.ly/2BWadoE Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-China National Medicines' 9-month net profit up 9.1 pct y/y

* Says 9-month net profit up 9.1 percent y/y a t 835.8 million yuan ($125.83 million)

BRIEF-China National Medicines Corp to provide loan of up to 400 mln yuan to controlling bio-medicine unit

* Says it plans to provide loan of up to 400 million yuan to Beijing-based controlling biological medicine subsidiary

BRIEF-China National Medicines' H1 net profit up 10.8 pct y/y

* Says H1 net profit up 10.8 percent y/y at 553.9 million yuan ($83.14 million)

BRIEF-China National Medicines sees H1 net profit up strongly

* Says it expects H1 net profit to rise to 511.0-569.5 million yuan from 292.0 million yuan ($43.02 million) year ago

BRIEF-China National Medicines Corporation to provide loan of up to 200 mln yuan to controlling unit

* Says it plans to provide loan of up to 200 million yuan to Beijing controlling unit

BRIEF-China National Medicines to pay FY 2016 annual div on May 12

* Says it will pay cash dividend of 2 yuan per 10 shares (before tax) for every 10 shares to shareholders of record on May 11, for FY 2016

BRIEF-China National Medicines to pay annual div as 2 yuan/10 shares for FY 2016

* Says it will pay annual cash dividend as 2 yuan(pre-tax)/10 shares to shareholders for FY 2016

BRIEF-China National Medicines gets regulatory approval for asset acquisition

* Says it gets securities regulator's approval for asset acquisition

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up